Pharmatory
Oulu, Finland
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Pharmatory
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Oulu, Finland
- Website
- https://www.pharmatory.com/
- Modalities
- Small Molecule API, Intermediates, Veterinary
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Pharmatory
Pharmatory is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Intermediates, Veterinary. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.pharmatory.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Frequently Asked Questions About Pharmatory
Does Pharmatory have a CDMO Signal Score?
Not yet. Pharmatory is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Pharmatory for a manufacturing program?
Use the free AI matchmaker to compare Pharmatory against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Changzhou Qihui Pharmaceutical
Changzhou, Jiangsu, China
Small Molecule API, Veterinary, Intermediates
Sun Chemical (Japan)
Yashio, Saitama, Japan
Small Molecule API, Intermediates, Veterinary
Axplora
Paris, France
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
ICROM
Concorezzo (MB), Italy
Small Molecule API, Intermediates, Custom Synthesis
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Compare Pharmatory with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.